Skip to main content

Hormone Therapy: Individualizing Treatment Based Upon Perimenopausal Symptoms

  • Chapter
  • First Online:
Hormone Therapy
  • 1473 Accesses

Abstract

All FDA-approved systemic estrogen formulations relieve hot flushes. However, menopausal symptoms are not always equivalent to estrogen deficiency. Women in their 40s have varying estradiol levels based upon BMI, ethnicity and other factors. I believe that progesterone has an important role in treating menopausal symptoms and balancing estradiol. Symptoms of high estradiol, such as breast tenderness and enlargement, increased irritability, and frequent awakening (without night sweats), may be best treated with progesterone alone. Administration of estradiol to women with already high (or spiking) estradiol levels may also result in weight gain. While guidelines recommend using hormones for the shortest time possible, I do not believe that women should be encouraged to discontinue them if they feel well and desire to continue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Gleason CE, Schmitz TW, Hess T, et al. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology. 2006;67: 2039–41.

    Article  PubMed  CAS  Google Scholar 

  2. Gruber DM, Huber JC. Tissue specificity: the clinical importance of steroid metabolites in hormone replacement therapy. Maturitas. 2001;37:151–7.

    Article  PubMed  CAS  Google Scholar 

  3. L’Hermite ML, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol + progesterone be a safer postmenopausal HRT?A review. Maturitas. 2008;60: 185–201.

    Article  PubMed  Google Scholar 

  4. Mather KJ, Norman EG, Prior JC, Elliott T. Preserved forearm endothelial responses with acute exposure to progesterone: a randomized cross-over trial of 17-β estradiol, progesterone, and 17-β estradiol with progesterone in healthy menopausal women. J Clin Endocrinol Metab. 2000;85(12):4644–9.

    Article  PubMed  CAS  Google Scholar 

  5. Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause. 2001;8(1):10–6.

    Article  PubMed  CAS  Google Scholar 

  6. Tremollieres F, Brincat M, Erel CT. EMAS position statement: managing menopausal women with a personal or family history of VTE. Maturitas. 2011;69:190–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). Hormone Therapy: Individualizing Treatment Based Upon Perimenopausal Symptoms. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics